These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15050191)

  • 1. IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine?
    Miossec P
    Joint Bone Spine; 2004 Mar; 71(2):87-90. PubMed ID: 15050191
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine networks--towards new therapies for rheumatoid arthritis.
    McInnes IB; Liew FY
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti cytokine therapy in chronic inflammatory arthritis.
    Thompson C; Davies R; Choy E
    Cytokine; 2016 Oct; 86():92-99. PubMed ID: 27497159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of the cytokinome in undifferentiated arthritis progressing to rheumatoid arthritis and its change in the course of therapy. Move toward personalized medicine.
    Brzustewicz E; Bzoma I; Daca A; Szarecka M; Bykowska MS; Witkowski JM; Bryl E
    Cytokine; 2017 Sep; 97():1-13. PubMed ID: 28551592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis.
    Ndongo-Thiam N; Clement A; Pin JJ; Razanajaona-Doll D; Miossec P
    Ann Rheum Dis; 2016 Jul; 75(7):1420-2. PubMed ID: 27130907
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment.
    Shirinsky IV; Zheltova OI; Solovyova NY; Kozlov VA; Shirinsky VS
    Scand J Rheumatol; 2009; 38(1):23-7. PubMed ID: 18830905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.
    Lee SJ; Park W; Park SH; Shim SC; Baek HJ; Yoo DH; Kim HA; Lee SK; Leee YJ; Park YE; Cha HS; Park JK; Lee EY; Lee EB; Song YW
    J Immunol Res; 2015; 2015():487230. PubMed ID: 25922848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine targeting in rheumatoid arthritis.
    Bui VL; Brahn E
    Clin Immunol; 2019 Sep; 206():3-8. PubMed ID: 29621613
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic Potential of Sclareol in Experimental Models of Rheumatoid Arthritis.
    Tsai SW; Hsieh MC; Li S; Lin SC; Wang SP; Lehman CW; Lien CZ; Lin CC
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab reduces the frequency of interleukin 17-producing cells and the amounts of interleukin 17 in patients with rheumatoid arthritis.
    Shen H; Xia L; Lu J; Xiao W
    J Investig Med; 2010 Oct; 58(7):905-8. PubMed ID: 20601897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.
    Osiri M; Wongpiyabovorn J; Sattayasomboon Y; Thammacharoenrach N
    Clin Rheumatol; 2016 Jul; 35(7):1673-81. PubMed ID: 27188857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
    Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW
    Br J Rheumatol; 1995 Aug; 34(8):747-55. PubMed ID: 7551660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatoid arthritis and cytokines].
    Kaneko S; Kondo Y; Yokosawa M; Sumida T
    Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17, now an important target for treatment in arthritis!
    Miossec P
    Joint Bone Spine; 2017 May; 84(3):247-249. PubMed ID: 28017822
    [No Abstract]   [Full Text] [Related]  

  • 18. The mode of action of cytokine inhibitors.
    Arend WP
    J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis.
    Taylor PC
    Curr Pharm Des; 2003; 9(14):1095-106. PubMed ID: 12769749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.